BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 11848545)

  • 1. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
    Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of gallium-67 citrate and technetium-99m tetrofosmin scan to detect Hodgkin's disease.
    Liu FY; Shiau YC; Yen RF; Wang JJ; Ho ST; Kao CH
    Ann Nucl Med; 2003 Sep; 17(6):439-42. PubMed ID: 14575376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m tetrofosmin scintigraphy for detecting malignant lymphoma.
    Lee JK; Tsai SC; Ho YJ; Changlai SP; Kao CH
    Anticancer Res; 2001; 21(2B):1509-13. PubMed ID: 11396241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY; Kao A; Yen RF
    Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of technetium-99m tetrofosmin scan to detect non-Hodgkin's lymphoma.
    Liu FY; Shiau YC; Kao A; Liang JA; Yang SN
    Anticancer Res; 2003; 23(3C):2951-3. PubMed ID: 12926142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m-tetrofosmin scintigraphy in the prediction of chemotherapy response of untreated malignant lymphomas and comparison with other prognostic factors.
    Sun SS; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
    Anticancer Res; 2001; 21(1B):685-8. PubMed ID: 11299826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
    Apostolopoulos DJ; Papandrianos NI; Symeonidis A; Spyridonidis T; Alexiou S; Zampakis P; Savvopoulos C; Vassilakos PJ; Matsouka P
    Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma.
    Waxman AD; Eller D; Ashook G; Ramanna L; Brachman M; Heifetz L; McAndrews P; Bierman H; Taub R; Avedo M; Wall F
    J Nucl Med; 1996 Jan; 37(1):46-50. PubMed ID: 8544000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of low-grade gastric MALT lymphoma and high-grade gastric MALT lymphoma: the clinical value of Ga-67 citrate scintigraphy--a pilot study.
    Hsu CH; Sun SS; Kao CH; Lin CC; Lee CC
    Cancer Invest; 2002; 20(7-8):939-43. PubMed ID: 12449725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.
    Li S; Kurtaran A; Li M; Traub-Weidinger T; Kienast O; Schima W; Angelberger P; Virgolini I; Raderer M; Dudczak R
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1087-95. PubMed ID: 12768334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallium-67 and technetium-99m-MDP scintigraphy for osseous involvement in lymphoma.
    Van de Wiele C; Dierckx RA; Simons M; Noens L
    J Nucl Med; 1996 Mar; 37(3):548. PubMed ID: 8772667
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic efficacy of technetium-99m pentavalent-dimercapto succinic acid versus gallium-67 citrate, imaging in patients with highly suspected acute bone and joint infections.
    Koukouraki S; Gaitanis I; Hatjipaulou A; Karkavitsas N
    Hell J Nucl Med; 2006; 9(2):99-102. PubMed ID: 16894413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of gallium-67 citrate scintigraphy in gastro-intestinal malignant lymphoma].
    Kataoka M; Tsuda T; Kawamura M; Itoh H; Komatsu A; Mogami H; Tanada S; Iio A; Hamamoto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):155-63. PubMed ID: 2362795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ga-67 citrate and Tc-99m pertechnetate scintigraphy in thyroid lymphoma.
    Bhatnagar P; Sahu M; Jain M; Rawat H; Bhatnagar A; Kashyap R
    Clin Nucl Med; 2004 Jan; 29(1):51-2. PubMed ID: 14688602
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of 67 Ga citrate and 99m Tc bone scintigraphy at initial examination for primary oral squamous cell carcinoma.
    Onizawa K; Yoshida H
    J Oral Maxillofac Surg; 2003 Aug; 61(8):913-7. PubMed ID: 12905444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
    Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
    Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ga-67 scintigraphy for the localization and staging of malignant lymphoma].
    Monzawa S; Karikomi M; Uno K; Itami J; Arimizu N
    Gan No Rinsho; 1988 Aug; 34(9):1059-64. PubMed ID: 3172511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US.
    Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S
    Eur J Nucl Med; 2001 Dec; 28(12):1817-27. PubMed ID: 11734921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone lymphoma. Comparison of Tl-201 and Ga-67 citrate scintigraphy in assessment of treatment response.
    Roach PJ; Janicek MJ; Kaplan WD
    Clin Nucl Med; 1996 Sep; 21(9):689-94. PubMed ID: 8879868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualization of esophageal non-Hodgkin's lymphoma with Ga-67 scintigraphy.
    Nishryama Y; Yamamoto Y; Ono Y; Satoh K; Ohkawa M; Yamauchi A; Tanabe M
    Ann Nucl Med; 1999 Dec; 13(6):419-21. PubMed ID: 10656277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.